Astellas Pharma (TSE:4503) Other Long-Term Liabilities : 円221,378 Mil (As of Dec. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Astellas Pharma Other Long-Term Liabilities?

Astellas Pharma's other long-term liabilities for the quarter that ended in Dec. 2023 was 円221,378 Mil.

Astellas Pharma's quarterly other long-term liabilities increased from Jun. 2023 (円150,917 Mil) to Sep. 2023 (円243,856 Mil) but then declined from Sep. 2023 (円243,856 Mil) to Dec. 2023 (円221,378 Mil).

Astellas Pharma's annual other long-term liabilities declined from Mar. 2021 (円256,159 Mil) to Mar. 2022 (円147,450 Mil) but then increased from Mar. 2022 (円147,450 Mil) to Mar. 2023 (円197,712 Mil).

Astellas Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Astellas Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Other Long-Term Liabilities Chart

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Astellas Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Astellas Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (TSE:4503) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (TSE:4503) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

ALPMY:USA ALPMF:USA 4503:Mexico YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Astellas Pharma (TSE:4503) Headlines

No Headlines